Search

everythinglearnresearchcommunity

for

Search:↓

Spin traps like PBN could protect skin from pollution and sunlight in cosmetics but need more research for safe use.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Pregnancy can cause skin changes and affect existing skin conditions, with limited treatment options due to the need for fetal safety.

Herbal lotions are effective for severe hair loss, with a 64.8% success rate, but relapse is common and long-term management requires allergen control and possible corticosteroid use.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

Human skin can make serotonin and melatonin, which help protect and maintain it.

Visible light can damage skin and most sunscreens don't block it well; more research is needed on its effects and protection methods.

Alopecia areata can cause unpredictable hair loss, and treatments like corticosteroids and minoxidil may help but have varying side effects.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

The article concludes that advancements in hair cosmetics require dermatologists to stay informed about products and their potential risks, including allergies and higher risks for hairdressers.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

The study suggests that acne keloidalis nuchae is linked to conditions like pseudofolliculitis barbae, scalp infections, metabolic syndrome, and is more common in males with an average onset age of 25.4 years.

Most pregnant women experience skin changes like darkening and itching, while serious skin conditions are rare but need early treatment.

Recognizing and managing skin-related psychiatric disorders in children is crucial for effective treatment.

Both emollients effectively reduced itching and improved skin moisture in xerotic eczema.

Skin doctors should recognize and treat conditions like hair-pulling and skin-picking early, often using therapy and medication, to help 50-70% of patients.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Women who had bariatric surgery risk nutritional deficiencies causing skin issues during pregnancy and breastfeeding.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.

New genes linked to ichthyosis were found, but there's still no cure; treatment options are improving.

A man lost all his hair permanently after hepatitis C treatment, a side effect not seen before.

Older women often have vulva issues due to less estrogen, which can be misdiagnosed and lead to wrong treatments.